MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
shares under the sales...
$4,862,393
Capital contribution
$3,500,000
Proceeds from loan
agreement
$3,400,000
Net (decrease)
increase in cash
-$730,623
Net cash provided by
financing activities
$11,662,393
Canceled cashflow
$100,000
Net (decrease)
increase in cash
-$730,623
Canceled cashflow
$11,662,393
Stock-based compensation
expense
$16,222,861
Amortization of right-of-use
asset
$318,624
Depreciation expense
$190,573
Prepaid expenses and
other assets
-$101,838
Payment of offering
costs associated with...
$100,000
Net cash used in
operating activities
-$12,328,577
Canceled cashflow
$16,833,896
Net cash used in
investing activities
-$64,439
Net loss
-$26,275,432
Accounts payable
-$1,964,118
Other assets
$490,043
Operating lease
liabilities
-$297,976
Accrued expenses and
other liabilities
-$74,203
Change in fair value of
warrants
-$60,701
Purchases of property and
equipment
$64,439
Back
Back
Cash Flow
source: myfinsight.com
Tevogen Bio Holdings Inc. (TVGNW)
Tevogen Bio Holdings Inc. (TVGNW)